PMCTPharmaCountry
    홈

규제 업데이트

FDA, EMA, TGA 및 글로벌 규제 동향

#ointment ×

UPDATED
규제 업데이트
2026년 8월 30일•1분 읽기
FDA Discontinues FLUTEX Topical Ointment (ANDA087377)
FDA records indicate the FLUTEX topical ointment (0.1% Triamcinolone Acetoinide) by IVAX PHARMS is discontinued, with original ANDA approval in 1988 and a labeling supplement in 1992.
1
UPDATED
규제 업데이트
2026년 8월 27일•1분 읽기
FDA Announces Discontinued Ophthalmic Ointment DEXAIR (ANDA088071)
The FDA’s ANDA088071 filing shows that DEXAIR ophthalmic ointment, containing 0.05% dexamethasone sodium phosphate, is marked discontinued by sponsor PharmaFair.